Spots Global Cancer Trial Database for triptorelin
Every month we try and update this database with for triptorelin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | NCT02742675 | Prostate Cancer | Bicalutamide goserelin aceta... flutamide leuprolide acet... triptorelin Definitive Trea... | 18 Years - 80 Years | Fudan University | |
| Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | NCT00667069 | Prostate Cancer | triptorelin adjuvant therap... 3-dimensional c... | 18 Years - | UNICANCER | |
| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | NCT02742675 | Prostate Cancer | Bicalutamide goserelin aceta... flutamide leuprolide acet... triptorelin Definitive Trea... | 18 Years - 80 Years | Fudan University | |
| Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | NCT00667069 | Prostate Cancer | triptorelin adjuvant therap... 3-dimensional c... | 18 Years - | UNICANCER | |
| Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score | NCT05050084 | Prostate Adenoc... | Bicalutamide Buserelin Darolutamide Degarelix Flutamide Goserelin Histrelin Leuprolide Radiation Thera... Relugolix Triptorelin | 18 Years - | NRG Oncology | |
| A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer | NCT05896566 | Breast Cancer | Giredestrant Triptorelin Anastrozole | 18 Years - | ETOP IBCSG Partners Foundation | |
| Hormone Therapy in Treating Patients With Advanced Prostate Cancer | NCT00003026 | Prostate Cancer | bicalutamide flutamide triptorelin radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | NCT02102646 | Prostate Cancer Metabolic Syndr... Hypogonadism Fatty Liver | Triptorelin Orchiectomy | 18 Years - 90 Years | Herlev Hospital | |
| Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure | NCT01160315 | Fertility Prese... Alkylating Agen... Lymphoma | Triptorelin Norethisterone ... | 18 Years - 45 Years | Erasme University Hospital | |
| Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland | NCT05701007 | Metastatic Cast... Metastatic Cast... | abiraterone enzalutamide docetaxel apalutamide cabazitaxel Radium-223 Lutetium-177 degarelix goserelin leuprorelin triptorelin | 18 Years - | Pfizer | |
| Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia | NCT05800197 | Breast Cancer Neoadjuvant End... | Tamoxifen 20mg Anastrozole 1mg Letrozole 2.5mg Goserelin Triptorelin | 18 Years - | Blokhin's Russian Cancer Research Center | |
| Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer | NCT00066703 | Breast Cancer | exemestane tamoxifen triptorelin | 18 Years - 65 Years | ETOP IBCSG Partners Foundation | |
| Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer | NCT00090844 | Breast Cancer Hormone Changes Drug Toxicity | triptorelin | - 44 Years | University of South Florida | |
| Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | NCT00311636 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... epirubicin hydr... fluorouracil methotrexate paclitaxel triptorelin adjuvant therap... | 18 Years - 45 Years | National Cancer Institute (NCI) | |
| Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve | NCT02113553 | Breast Cancer | Triptorelin | - 40 Years | Istituto Clinico Humanitas | |
| Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer | NCT00090844 | Breast Cancer Hormone Changes Drug Toxicity | triptorelin | - 44 Years | University of South Florida | |
| Hormone Therapy in Treating Patients With Advanced Prostate Cancer | NCT00003026 | Prostate Cancer | bicalutamide flutamide triptorelin radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Premenopausal Endocrine Responsive Chemotherapy Trial | NCT00066807 | Breast Cancer | chemotherapy exemestane tamoxifen triptorelin oophorectomy ovarian irradia... | 18 Years - 65 Years | ETOP IBCSG Partners Foundation | |
| MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | NCT02102646 | Prostate Cancer Metabolic Syndr... Hypogonadism Fatty Liver | Triptorelin Orchiectomy | 18 Years - 90 Years | Herlev Hospital | |
| Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | NCT00311636 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... epirubicin hydr... fluorouracil methotrexate paclitaxel triptorelin adjuvant therap... | 18 Years - 45 Years | National Cancer Institute (NCI) | |
| Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients | NCT01764230 | Hodgkin Lymphom... Hodgkin Disease | triptorelin | 18 Years - 35 Years | Masaryk University | |
| Micro RNAs to Predict Response to Androgen Deprivation Therapy | NCT02366494 | Prostate Cancer | Bicalutamide Leuprolide Goserelin Triptorelin Docetaxel Abiraterone Apalutamide Enzalutamide | 21 Years - 85 Years | Medical College of Wisconsin | |
| HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. | NCT00412022 | Breast Cancer | tamoxifen triptorelin letrozole zoledronic acid | 18 Years - | National Cancer Institute, Naples | |
| Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer | NCT05982093 | Breast Cancer HER2-negative B... Hormone Recepto... Premenopausal B... | Elacestrant Triptorelin | 35 Years - | SOLTI Breast Cancer Research Group | |
| Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial | NCT06378866 | Recurrent Castr... Stage IVB Prost... Recurrent Prost... Castration-resi... | Abiraterone Apalutamide Biospecimen Col... Bone Scan Computed Tomogr... Darolutamide Degarelix Enzalutamide Goserelin Histrelin Leuprolide Magnetic Resona... Patient Observa... Positron Emissi... Prednisone Questionnaire A... Relugolix Stereotactic Bo... Triptorelin | 18 Years - | Mayo Clinic | |
| Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging | NCT04423211 | Biochemically R... Metastatic Pros... Prostate Adenoc... Stage IVB Prost... | 3-Dimensional C... Apalutamide Computed Tomogr... Degarelix External Beam R... Fluciclovine F1... Goserelin Aceta... Intensity-Modul... Intensity-Modul... Leuprolide Acet... Magnetic Resona... Positron Emissi... Quality-of-Life... Questionnaire A... Relugolix Stereotactic Bo... Triptorelin Volume Modulate... | 18 Years - | Eastern Cooperative Oncology Group | |
| Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | NCT00667069 | Prostate Cancer | triptorelin adjuvant therap... 3-dimensional c... | 18 Years - | UNICANCER | |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | NCT03678025 | Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin | 18 Years - | SWOG Cancer Research Network | |
| Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients | NCT04659551 | Breast Cancer | Epirubicin Cyclophosphamid... Triptorelin Exemestane Nivolumab | 18 Years - | Istituto Oncologico Veneto IRCCS | |
| Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer | NCT02278185 | Adenocarcinoma ... Recurrent Prost... Stage III Prost... Stage IV Prosta... | Enzalutamide leuprolide acet... goserelin aceta... histrelin aceta... triptorelin degarelix | 19 Years - | University of Colorado, Denver | |
| Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer | NCT02238366 | Prostate Cancer | triptorelin | 18 Years - | Ipsen | |
| Management of Castration-Resistant Prostate Cancer With Oligometastases | NCT02685397 | Castration-resi... | Leuprolide Acet... Goserelin Aceta... Triptorelin Enzalutamide Stereotactic Bo... | 18 Years - | Sir Mortimer B. Davis - Jewish General Hospital | |
| Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer | NCT00003734 | Prostate Cancer | flutamide triptorelin radiation thera... | 18 Years - 120 Years | National Cancer Institute (NCI) | |
| Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study | NCT04484818 | Prostate Carcin... | Darolutamide Goserelin Aceta... Leuprolide Acet... Placebo Adminis... Quality-of-Life... Triptorelin | 18 Years - | Eastern Cooperative Oncology Group | |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | NCT03678025 | Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin | 18 Years - | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
